Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Locarnini

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Antiviral Therapy|November 3, 2010
Molecular genetics of HBV infectionStephen Locarnini, Fabien Zoulim
Antiviral Therapy|February 21, 2008
Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIVStephen Locarnini, Nadia Warner
Clinics in Liver Disease|July 20, 2010
Drug resistance in antiviral therapyStephen Locarnini, Scott Bowden
Expert Review of Anti-Infective Therapy|November 30, 2004
Entecavir for the treatment of chronic hepatitis BTim Shaw, Stephen Locarnini
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistanceFabien Zoulim, Stephen Locarnini
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 9, 2002
Antiviral therapy for hepatitis B virus infections: new targets and technical challengesJordan Feld, Stephen Locarnini
Hepatology (Baltimore, Md.)|June 10, 2008
The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral reboundNadia Warner, Stephen Locarnini
Reviews in Medical Virology|June 24, 2003
Treatment of chronic hepatitis B: current challenges and future directionsRuth Chin, Stephen Locarnini
Current Opinion in Virology|September 11, 2013
Hepatitis B antivirals and resistanceUma Devi, Stephen Locarnini
Clinics in Liver Disease|November 6, 2007
Genotyping and genomic sequencing in clinical practiceRobert G Gish, Stephen Locarnini
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Antiviral Therapy|November 3, 2010
Molecular genetics of HBV infectionStephen Locarnini, Fabien Zoulim
Antiviral Therapy|February 21, 2008
Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIVStephen Locarnini, Nadia Warner
Clinics in Liver Disease|July 20, 2010
Drug resistance in antiviral therapyStephen Locarnini, Scott Bowden
Expert Review of Anti-Infective Therapy|November 30, 2004
Entecavir for the treatment of chronic hepatitis BTim Shaw, Stephen Locarnini
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistanceFabien Zoulim, Stephen Locarnini
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 9, 2002
Antiviral therapy for hepatitis B virus infections: new targets and technical challengesJordan Feld, Stephen Locarnini
Hepatology (Baltimore, Md.)|June 10, 2008
The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral reboundNadia Warner, Stephen Locarnini
Reviews in Medical Virology|June 24, 2003
Treatment of chronic hepatitis B: current challenges and future directionsRuth Chin, Stephen Locarnini
Current Opinion in Virology|September 11, 2013
Hepatitis B antivirals and resistanceUma Devi, Stephen Locarnini
Clinics in Liver Disease|November 6, 2007
Genotyping and genomic sequencing in clinical practiceRobert G Gish, Stephen Locarnini
Pageof 14